Page last updated: 2024-11-11

gr 218231

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

GR 218231: a dopamine D3 receptor antagonist; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5312124
CHEMBL ID131556
SCHEMBL ID626977
MeSH IDM0363120

Synonyms (17)

Synonym
gtpl70
PDSP2_001398
gr218231
PDSP1_001414
gr 218231
gr-218,231
2-(di-n-propylamino)-6-(4-methoxyphenylsulfonylmethyl)-1,2,3,4-tetrahydronaphthalene
gr 218,231
CHEMBL131556 ,
(2r)-6-[(4-methoxyphenyl)sulfonylmethyl]-n,n-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine
175442-95-2
(+)-(2r)-1,2,3,4-tetrahydro-6-[[(4-methoxyphenyl)sulfonyl]methyl]-n,n-dipropyl-2-naphthalenamine
SCHEMBL626977
DTXSID70415546
(r)-6-((4-methoxyphenylsulfonyl)methyl)-n,n-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine
bdbm50214486
Q27077846

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The sensitivity of (11)C-GR218231 for P-glycoprotein modulation was assessed in dose-response studies, using escalating cyclosporine A dosages."( Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
de Vries, EF; Dijkstra, D; Elsinga, PH; Kortekaas, R; Vaalburg, W; van Waarde, A, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID624215Antagonists at Human 5-Hydroxytryptamine receptor 5-HT1A2000The Journal of pharmacology and experimental therapeutics, Jun, Volume: 293, Issue:3
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
AID1345615Human 5-HT1A receptor (5-Hydroxytryptamine receptors)2000The Journal of pharmacology and experimental therapeutics, Jun, Volume: 293, Issue:3
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]